Tower Research Capital LLC (TRC) - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$132,126
+113801.7%
3,439
-31.6%
0.00%0.0%
Q1 2023$116
+329.6%
5,029
+389.2%
0.00%
+300.0%
Q4 2022$27
-99.9%
1,028
-45.8%
0.00%0.0%
Q3 2022$37,000
-89.9%
1,897
-91.0%
0.00%
-87.5%
Q2 2022$367,000
+416.9%
20,986
+383.5%
0.01%
+700.0%
Q1 2022$71,000
-69.1%
4,340
-69.3%
0.00%
-75.0%
Q4 2021$230,000
+283.3%
14,127
+200.8%
0.00%
+100.0%
Q3 2021$60,0000.0%4,697
+9.8%
0.00%0.0%
Q2 2021$60,000
+150.0%
4,278
+173.5%
0.00%
Q1 2021$24,000
-64.2%
1,564
-63.1%
0.00%
-100.0%
Q4 2020$67,0004,2340.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders